Publications

  1. Watters CR, Barro O, Gabere M, Masuda MY, Elliott NM, Raupach EA, Ferdous KU, Tesfay MZ, Moaven O, Zhou Y, Barrett MT, Buetow KH, Nagalo BM, Borad MJ. Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma. Mol Ther Oncol. 2025 Mar 20; 33 (1):200937 Epub 2025 Jan 17
    View PubMed
  2. Tesfay MZ, Zhang Y, Ferdous KU, Taylor MA, Cios A, Shelton RS, Simoes CC, Watters CR, Barro O, Elliott NM, Mustafa B, Chamcheu JC, Graham AL, Washam CL, Alkam D, Gies A, Byrum SD, Giorgakis E, Post SR, Kelly T, Ying J, Moaven O, Chabu CY, Fernandez-Zapico ME, Duda DG, Roberts LR, Govindarajan R, Borad MJ, Cannon MJ, Basnakian AG, Nagalo BM. Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade. Mol Ther Oncol. 2024 Dec 19; 32 (4):200913 Epub 2024 Nov 26
    View PubMed
  3. Albadawi H, Zhang Z, Keum H, Cevik E, Nagalo BM, Gunduz S, Kita H, Oklu R. Percutaneous Delivery of Oncogel for Targeted Liver Tumor Ablation and Controlled Release of Therapeutics. Adv Mater. 2024 Nov; 36 (45):e2406080 Epub 2024 Aug 15
    View PubMed
  4. Eslinger C, Uson PLS Jr, Nagalo BM, Borad MJ. Spontaneous regression of advanced hepatocellular carcinoma following COVID-19 infection and vaccination: a case report and review of literature. J Gastrointest Oncol. 2024 Aug 31; 15 (4):1933-1938 Epub 2024 July 22
    View PubMed
  5. Bazie MM, Sanou M, Djigma FW, Compaore TR, Obiri-Yeboah D, Kabamba B, Nagalo BM, Simpore J, Ouedraogo R. Genetic diversity and occult hepatitis B infection in Africa: A comprehensive review. World J Hepatol. 2024 May 27; 16 (5):843-859
    View PubMed
  6. Watters CR, Barro O, Elliott NM, Zhou Y, Gabere M, Raupach E, Baker AT, Barrett MT, Buetow KH, Jacobs B, Seetharam M, Borad MJ, Nagalo BM. Multi-modal efficacy of a chimeric vesiculovirus expressing the Morreton glycoprotein in sarcoma. Mol Ther Oncolytics. 2023 Jun 15; 29:4-14. Epub 2023 Mar 01.
    View PubMed
  7. Nagalo BM, Zhou Y, Loeuillard EJ, Dumbauld C, Barro O, Elliott NM, Baker AT, Arora M, Bogenberger JM, Meurice N, Petit J, Uson PLS Jr, Aslam F, Raupach E, Gabere M, Basnakian A, Simoes CC, Cannon MJ, Post SR, Buetow K, Chamcheu JC, Barrett MT, Duda DG, Jacobs B, Vile R, Barry MA, Roberts LR, Ilyas S, Borad MJ. Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers. Hepatology. 2023 Jun 01; 77(6):1943-1957. Epub 2022 Oct 11.
    View PubMed
  8. Zongo SV, Djigma FW, Yonli AT, Sorgho PA, Nagalo BM, Traore L, Somda D, Amegnona LJ, Languie E, Some CCB, Sia LMJ, Sourabie IB, Sombie RA, Serme AK, Obiri-Yeboah D, Simpore J. Association of DRB1*11 and DRB1*12 alleles of the HLA system with the evolution of the Hepatitis B virus infection in Burkina Faso. Mol Biol Rep. 2023 Jun; 50 (6):5039-5047 Epub 2023 Apr 26
    View PubMed
  9. Uson Junior PLS, DeLeon TT, Bogenberger JM, Pai RK, Kosiorek HE, Yin J, Ahn DH, Sonbol MB, Bekaii-Saab T, Mansfield AS, Buetow K, Gores GJ, Smoot R, Vasmatzis G, Kipp BR, Mahipal A, Baker AT, Babiker H, Barro O, Dumbauld C, Zhou Y, Aslam FN, Barrett M, Jacobs B, Meurice N, Arora M, Petit J, Elliott N, Nagalo B, Salomao MA, Borad MJ. FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations. Dig Dis Sci. 2022 Aug; 67(8):3797-3805. Epub 2021 Nov 13.
    View PubMed
  10. Uson Junior PLS, Majeed U, Yin J, Botrus G, Sonbol MB, Ahn DH, Starr JS, Jones JC, Babiker H, Inabinett SR, Wylie N, Boyle AWR, Bekaii-Saab TS, Gores GJ, Smoot R, Barrett M, Nagalo B, Meurice N, Elliott N, Petit J, Zhou Y, Arora M, Dumbauld C, Barro O, Baker A, Bogenberger J, Buetow K, Mansfield A, Mody K, Borad MJ. Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy. JCO Precis Oncol. 2022 Jun; 6 (1):e2100274
    View PubMed
  11. Dumbauld C, Gabere M, Barro O, Nagalo BM, Borad M. Pancreatic cancer models exhibit interferon-independent resistance mechanisms to a Morreton hybrid oncolytic vesiculovirus. European Journal of Cancer. 2022; 174:S128
  12. Arora M, Bogenberger JM, Abdelrahman AM, Yonkus J, Alva-Ruiz R, Leiting JL, Chen X, Serrano Uson Junior PL, Dumbauld CR, Baker AT, Gamb SI, Egan JB, Zhou Y, Nagalo BM, Meurice N, Eskelinen EL, Salomao MA, Kosiorek HE, Braggio E, Barrett MT, Buetow KH, Sonbol MB, Mansfield AS, Roberts LR, Bekaii-Saab TS, Ahn DH, Truty MJ, Borad MJ. Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancers. Hepatology. 2022 Jan; 75 (1):43-58 Epub 2021 Dec 12
    View PubMed
  13. Baker AT, Boyd RJ, Sarkar D, Teijeira-Crespo A, Chan CK, Bates E, Waraich K, Vant J, Wilson E, Truong CD, Lipka-Lloyd M, Fromme P, Vermaas J, Williams D, Machiesky L, Heurich M, Nagalo BM, Coughlan L, Umlauf S, Chiu PL, Rizkallah PJ, Cohen TS, Parker AL, Singharoy A, Borad MJ. ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome. Sci Adv. 2021 Dec 3; 7 (49):eabl8213 Epub 2021 Dec 01
    View PubMed
  14. Uson Junior PLS, Nagalo BM, Ahn DH, Bekaii-Saab T, Borad MJ. Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently? Semin Liver Dis. 2021 May; 41 (2):136-141 Epub 2021 May 06
    View PubMed
  15. Roy T, Boateng ST, Banang-Mbeumi S, Singh PK, Basnet P, Chamcheu RN, Ladu F, Chauvin I, Spiegelman VS, Hill RA, Kousoulas KG, Nagalo BM, Walker AL, Fotie J, Murru S, Sechi M, Chamcheu JC. Identification of new fisetin analogs as kinase inhibitors: Data on synthesis and anti-skin cancer activities evaluation. Data Brief. 2021 Apr; 35:106858 Epub 2021 Feb 10
    View PubMed
  16. Wongjarupong N, Oli S, Sanou M, Djigma F, Kiba Koumare A, Yonli AT, Hassan MA, Mara K, Harmsen WS, Therneau T, Barro O, Vodounhessi G, Sawadogo S, Chamcheu JC, Simpore J, Roberts LR, Nagalo BM. Distribution and Incidence of Blood-Borne Infection among Blood Donors from Regional Transfusion Centers in Burkina Faso: A Comprehensive Study. Am J Trop Med Hyg. 2021 Feb 22; 104 (4):1577-1581
    View PubMed
  17. Roy T, Boateng ST, Banang-Mbeumi S, Singh PK, Basnet P, Chamcheu RN, Ladu F, Chauvin I, Spiegelman VS, Hill RA, Kousoulas KG, Nagalo BM, Walker AL, Fotie J, Murru S, Sechi M, Chamcheu JC. Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers. Bioorg Chem. 2021 Feb; 107:104595 Epub 2020 Dec 30
    View PubMed
  18. Wongjarupong N, Yonli AT, Nagalo BM, Djigma FW, Somda SK, Hassan MA, Mohamed EA, Sorgho AP, Compaore TR, Soubeiga ST, Kiendrebeogo I, Sanou M, Diarra B, Yang HI, Chen CJ, Ouattara AK, Zohoncon TM, Martinson JJ, Buetow K, Chamcheu JC, Antwi SO, Borad MJ, Simpore J, Roberts LR. Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina Faso. Hepatol Commun. 2020 Dec; 4 (12):1781-1792 Epub 2020 Sept 15
    View PubMed
  19. Nagalo BM, Breton CA, Zhou Y, Arora M, Bogenberger JM, Barro O, Steele MB, Jenks NJ, Baker AT, Duda DG, Roberts LR, Russell SJ, Peng KW, Borad MJ. Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers. Mol Ther Oncolytics. 2020 Sep 25; 18:546-555 Epub 2020 Aug 19
    View PubMed
  20. Arora M, Bogenberger JM, Abdelrahman A, Leiting JL, Chen X, Egan JB, Kasimsetty A, Lenkiewicz E, Malasi S, Uson PLS, Nagalo BM, Zhou Y, Salomao MA, Kosiorek HE, Braggio E, Barrett MT, Truty MJ, Borad MJ. Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer. Cancer Chemother Pharmacol. 2020 Jun; 85 (6):1063-1078 Epub 2020 May 21
    View PubMed
  21. Bayala B, Coulibaly AY, Djigma FW, Nagalo BM, Baron S, Figueredo G, Lobaccaro JA, Simpore J. Chemical composition, antioxidant, anti-inflammatory and antiproliferative activities of the essential oil of Cymbopogon nardus, a plant used in traditional medicine. Biomol Concepts. 2020 Apr 15; 11 (1):86-96
    View PubMed
  22. Bayala B, Coulibaly AY, Djigma FW, Nagalo BM, Baron S, Figueredo G, Lobaccaro JA, Simpore J. Chemical composition, antioxidant, anti-inflammatory and antiproliferative activities of the essential oil of Cymbopogon nardus, a plant used in traditional medicine. Biomol Concepts. 2020 Apr 15; 11 (1):86-96
    View PubMed
  23. Sorgho PA, Djigma FW, Martinson JJ, Yonli AT, Nagalo BM, Compaore TR, Diarra B, Sombie HK, Simpore A, Zongo AW, Ouattara AK, Soubeiga STR, Traore L, Yelemkoure ET, Kiendrebeogo IT, Roberts LR, Simpore J. Role of Killer cell immunoglobulin-like receptors (KIR) genes in stages of HIV-1 infection among patients from Burkina Faso. Biomol Concepts. 2019 Dec 19; 10 (1):226-236
    View PubMed
  24. Eko Mba JM, Bisseye C, Mombo LE, Ntsame Ndong JM, Mbina Ekayeng SC, Bengone C, M'batchi B, Nagalo BM. Assessment of rapid diagnostic tests and fourth-generation Enzyme-Linked Immunosorbent Assays in the screening of Human Immunodeficiency and Hepatitis B virus infections among first-time blood donors in Libreville (Gabon). J Clin Lab Anal. 2019 Mar; 33 (3):e22824 Epub 2018 Nov 28
    View PubMed
  25. Bisseye C, Eko Mba JM, Ntsame Ndong JM, Kosiorek HE, Butterfield RJ, Mombo LE, M'batchi B, Borad MJ, Nagalo BM, Allain JP. Decline in the seroprevalence of syphilis markers among first-time blood donors in Libreville (Gabon) between 2004 and 2016. BMC Public Health. 2019 Feb 8; 19 (1):167 Epub 2019 Feb 08
    View PubMed
  26. Bisseye C, Ndong JMN, Mombo LE, Mamberi HCM, Migolet GM, Taty-Taty GC, Nagalo BM. Hemogram abnormalities in apparently healthy first-time blood donors in Libreville, Gabon Sudan Journal Of Medical Sciences. 2019; 14 (3):103-15
  27. DeLeon TT, Zhou Y, Nagalo BM, Yokoda RT, Ahn DH, Ramanathan RK, Salomao MA, Aqel BA, Mahipal A, Bekaii-Saab TS, Borad MJ. Novel immunotherapy strategies for hepatobiliary cancers. Immunotherapy. 2018 Sep; 10 (12):1077-1091
    View PubMed
  28. Yokoda RT, Nagalo BM, Borad MJ. Oncolytic Adenoviruses in Gastrointestinal Cancers. Biomedicines. 2018 Mar 11; 6 (1)
    View PubMed
  29. Eko Mba JM, Bisseye C, Ntsame Ndong JM, Mombo LE, Bengone C, Mouelet Migolet G, M'batchi B, Kosiorek HE, Butterfield RJ, Roberts LR, Borad MJ, Nagalo BM. Prevalent hepatitis B surface antigen among first-time blood donors in Gabon. PLoS One. 2018; 13 (4):e0194285 Epub 2018 Apr 13
    View PubMed
  30. Sorgho PA, Martinson JJ, Djigma FW, Yonli AT, Nagalo BM, Compaore TR, Obiri-Yeboah D, Diarra B, Sombie HK, Zongo AW, Ouattara AK, Soubeiga STR, Traore L, Roberts LR, Simpore J. Insights into the Interplay between KIR Gene Frequencies and Chronic HBV Infection in Burkina Faso. Mediterr J Hematol Infect Dis. 2018; 10 (1):e2018060 Epub 2018 Nov 01
    View PubMed
  31. Diarra B, Yonli AT, Sorgho PA, Compaore TR, Ouattara AK, Zongo WA, Tao I, Traore L, Soubeiga ST, Djigma FW, Obiri-Yeboah D, Nagalo BM, Pietra V, Sanogo R, Simpore J. Occult Hepatitis B Virus Infection and Associated Genotypes among HBsAg-negative Subjects in Burkina Faso. Mediterr J Hematol Infect Dis. 2018; 10 (1):e2018007 Epub 2018 Jan 01
    View PubMed
  32. Bisseye C, Mombo LE, Bie SMM, Edou A, Eko-Mba JM, Etho-Mengue JC, Mbacky K, Mongo-Delis A, M'batchi B, Nagalo BM. Trends of blood-borne infectious diseases in a rural blood donation center of southeast Gabon (Koula-Moutou). Pan Afr Med J. 2018; 31:81 Epub 2018 Oct 03
    View PubMed
  33. Bisseye C, Ndong JMN, Matoumba AM, Bengone C, Migolet GM, Nagalo BM. Comparison of electrochemiluminescence and ELISA methods in the detection of blood borne pathogens in Gabon Asian Pacific Journal of Tropical Biomedicine.2017 Sep;7:(9):805808.
  34. Yokoda R, Nagalo BM, Arora M, Egan JB, Bogenberger JM, DeLeon TT, Zhou Y, Ahn DH, Borad MJ. Oncolytic virotherapy in upper gastrointestinal tract cancers. Oncolytic Virother. 2017; 7:13-24 Epub 2018 Mar 23
    View PubMed
  35. Yokoda R, Nagalo BM, Vernon B, Oklu R, Albadawi H, DeLeon TT, Zhou Y, Egan JB, Duda DG, Borad MJ. Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect. Oncolytic Virother. 2017; 6:39-49 Epub 2017 Nov 08
    View PubMed
  36. Sanou M, Soubeiga ST, Bationo F, Compaore TR, Zohoncon TM, Diatto GN, Ouedraogo P, Pietra V, Nagalo BM, Bisseye C, Traore RO, Simpore J. A decade of follow-up and therapeutic drug monitoring in HIV-2 immunocompromised patients at St Camille and General Lamizana Military Medical Centers, Burkina Faso, West Africa. Pak J Biol Sci. 2014 Dec; 17 (12):1219-24
    View PubMed
  37. Sawadogo ML, Nagalo BM, Compaore RT, Baky J, Simpore J. Poultry farming challenges in Burkina Faso: improving zootechnical performance of local chickens by hybridization Global Journal for Research Analysis. 2014 Dec; 3(12):139-41.
  38. Zeba MT, Sanou M, Bisseye C, Kiba A, Nagalo BM, Djigma FW, Compaore TR, Nebie YK, Kienou K, Sagna T, Pietra V, Moret R, Simpore J. Characterisation of hepatitis C virus genotype among blood donors at the regional blood transfusion centre of Ouagadougou, Burkina Faso. Blood Transfus. 2014 Jan; 12 Suppl 1:s54-7
    View PubMed
  39. Sanou M, Ky A, Ouangre E, Bisseye C, Sanou A, Nagalo BM, Sanou D, Simpore J, Sangare L, Traore R. [Characterization of bacterial flora in community peritonitis carried out in Burkina Faso]. Pan Afr Med J. 2014; 18:17 Epub 2014 May 05
    View PubMed
  40. Simpore A, Bisseye C, Nagalo BM, Sanou M, Nebie Y, Ghoma-Linguissi LS, Dahourou H, Sawadogo B, Djigma F, Ouattara S, Pietra V, Nichol J, Simpore J. Importance of extending the use of polymerase chain reaction in the diagnosis of venereal syphilis in a blood transfusion center in Burkina Faso, West Africa. Pan Afr Med J. 2014; 18:56 Epub 2014 May 15
    View PubMed
  41. Sanou M, Palenfo D, Bisseye C, Nagalo BM, Simpore J, Sangare L, Traore R. [Molecular diagnosis of bacterial meningitis in Burkina Faso]. Med Sante Trop. 2013 Jan-Mar; 23 (1):93-9
    View PubMed
  42. Tao I, Bisseye C, Nagalo BM, Sanou M, Kiba A, Surat G, Compaore TR, Traore L, Nikiema JB, Pietra V, Zongo JD, Simpore J. Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa. Mediterr J Hematol Infect Dis. 2013; 5 (1):e2013053 Epub 2013 Sept 02
    View PubMed
  43. Bisseye C, Sanou M, Nagalo BM, Kiba A, Compaore TR, Tao I, Simpore J. Epidemiology of syphilis in regional blood transfusion centres in Burkina Faso, West Africa. Pan Afr Med J. 2013; 16:69 Epub 2013 Oct 28
    View PubMed
  44. Linguissi LS, Bisseye C, Sagna T, Nagalo BM, Ouermi D, Djigma FW, Pignatelli S, Sia JD, Pietra V, Moret R, Nikiema JB, Simpore J. Efficiency of HAART in the prevention of mother to children HIV-1 transmission at Saint Camille medical centre in Burkina Faso, West Africa. Asian Pac J Trop Med. 2012 Dec; 5 (12):991-4
    View PubMed
  45. Linguissi LS, Nagalo BM, Bisseye C, Kagone TS, Sanou M, Tao I, Benao V, Simpore J, Kone B. Seroprevalence of toxoplasmosis and rubella in pregnant women attending antenatal private clinic at Ouagadougou, Burkina Faso. Asian Pac J Trop Med. 2012 Oct; 5 (10):810-3
    View PubMed
  46. Nagalo BM, Bisseye C, Sanou M, Kienou K, Nebie YK, Kiba A, Dahourou H, Ouattara S, Nikiema JB, Moret R, Zongo JD, Simpore J. Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa. Trop Med Int Health. 2012 Feb; 17 (2):247-53 Epub 2011 Oct 12
    View PubMed
  47. Nagalo MB, Sanou M, Bisseye C, Kabore MI, Nebie YK, Kienou K, Kiba A, Dahourou H, Ouattara S, Zongo JD, Simpore J. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009. Blood Transfus. 2011 Oct; 9 (4):419-24 Epub 2011 July 18
    View PubMed
  48. Nagalo BM, Bisseye C, Sanou M, Nebie YK, Kiba A, Kienou K, Zongo JD, Simpore J. [Molecular diagnosis of acquired human immunodeficiency virus (HIV) in pooled plasma from blood donors at the Regional Blood Transfusion Center in Ouagadougou, Burkina Faso]. Med Trop (Mars). 2011 Apr; 71 (2):137-41
    View PubMed